Sohliya, A. E. L. (2025). Revumenib: the newly approved food drug administration drug for the treatment of relapsed acute leukemia with a KMT2A translocation. International Journal of Research in Medical Sciences, 13(2), 987–988. https://doi.org/10.18203/2320-6012.ijrms20250291